• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals.

作者信息

Futterweit W, Deligdisch L

出版信息

J Clin Endocrinol Metab. 1986 Jan;62(1):16-21. doi: 10.1210/jcem-62-1-16.

DOI:10.1210/jcem-62-1-16
PMID:3940265
Abstract

The effects of exogenously administered testosterone were evaluated in a group of 19 female to male transsexuals who underwent bilateral salpingo-oophorectomy after a variable period of androgen therapy. The findings were compared to those in an age-matched group of 12 patients who underwent pelvic surgery for nonendocrine reasons. The most significant findings in the 19 androgen-treated female transsexuals was the finding of enlarged or borderline enlarged ovaries in 5 subjects. In addition, we found multiple cystic follicles in 17 patients (89.5%), diffuse ovarian stromal hyperplasia in 16 patients (84.2%), collagenization of the outer cortex in 13 patients, and 4) luteinization of stromal cells in 5 patients (26.3%). Findings consistent with polycystic ovaries were thus present in 13 of the 19 patients based on the presence of 3 of the above 4 findings. The data suggest that increased blood levels and presumably increased ovarian concentrations of testosterone may produce the morphological features of polycystic ovarian disease.

摘要

相似文献

1
Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals.
J Clin Endocrinol Metab. 1986 Jan;62(1):16-21. doi: 10.1210/jcem-62-1-16.
2
Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome?长期接受雄激素治疗的女变男跨性别者的卵巢形态学。多囊卵巢综合征研究的人类模型?
Histopathology. 1991 Nov;19(5):445-52. doi: 10.1111/j.1365-2559.1991.tb00235.x.
3
Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology.在处于生育年龄的女性转男性变性人(transsexual persons)中,过多的雄激素暴露会导致卵巢皮质和间质增生,但不会导致多囊卵巢形态。
Hum Reprod. 2013 Feb;28(2):453-61. doi: 10.1093/humrep/des385. Epub 2012 Nov 27.
4
The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.长期给予睾酮对性腺功能正常的女变男变性者促黄体生成素脉冲式分泌及卵巢组织学的影响。
J Clin Endocrinol Metab. 1989 Jul;69(1):151-7. doi: 10.1210/jcem-69-1-151.
5
Histology of genital tract and breast tissue after long-term testosterone administration in a female-to-male transsexual population.长期接受睾酮治疗的女性转男性变性人群的生殖器官和乳腺组织的组织学研究。
Reprod Biomed Online. 2010 Apr;20(4):553-8. doi: 10.1016/j.rbmo.2009.12.021. Epub 2009 Dec 24.
6
Polycystic ovary syndrome after menopause: a case report.
J Reprod Med. 2004 Jun;49(6):491-4.
7
[Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].[多囊卵巢综合征患者的支持-间质细胞瘤(男性细胞瘤):临床、超声、激素及组织病理学评估]
Srp Arh Celok Lek. 2001 May-Jun;129 Suppl 1:51-5.
8
The effects of long-term androgen treatment on the ovary.长期雄激素治疗对卵巢的影响。
Fertil Steril. 1986 Feb;45(2):202-8. doi: 10.1016/s0015-0282(16)49155-7.
9
The effect of androgen treatment on bone metabolism in female-to-male transsexuals.雄激素治疗对女变男变性者骨代谢的影响。
J Bone Miner Res. 1996 Nov;11(11):1769-73. doi: 10.1002/jbmr.5650111121.
10
Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.绝经后妇女的 Leydig 细胞增生和 Leydig 细胞瘤:两例报告。
Gynecol Endocrinol. 2013 Mar;29(3):213-5. doi: 10.3109/09513590.2012.705375. Epub 2012 Jul 26.

引用本文的文献

1
Psychological and Physical Health Outcomes Associated with Gender-Affirming Medical Care for Transgender and Gender-Diverse Youth: A Critical Review.与跨性别和性别多样化青少年性别肯定医疗护理相关的心理和身体健康结果:一项批判性综述。
Healthcare (Basel). 2025 Jul 10;13(14):1659. doi: 10.3390/healthcare13141659.
2
Incidence of gynaecological (pre-)malignancies and endometrial activity in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study.使用睾酮的跨性别男性及性别多样化个体中妇科(癌前)恶性肿瘤的发病率和子宫内膜活性:一项回顾性单中心队列研究
EClinicalMedicine. 2025 May 12;84:103248. doi: 10.1016/j.eclinm.2025.103248. eCollection 2025 Jun.
3
Uterine and Ovarian Histopathology After Testosterone for Gender Affirmation: A Systematic Review.
睾酮用于性别肯定后的子宫和卵巢组织病理学:一项系统评价
Transgend Health. 2024 Aug 16;9(4):288-297. doi: 10.1089/trgh.2022.0207. eCollection 2024 Aug.
4
One-third of amenorrheic transmasculine people on testosterone ovulate.三分之一接受睾酮治疗的闭经跨性别男性会排卵。
Cell Rep Med. 2024 Mar 19;5(3):101440. doi: 10.1016/j.xcrm.2024.101440. Epub 2024 Feb 22.
5
Reproductive capacity after gender-affirming testosterone therapy.性别肯定性雄激素治疗后的生殖能力。
Hum Reprod. 2023 Oct 3;38(10):1872-1880. doi: 10.1093/humrep/dead158.
6
Reproductive and Fertility Knowledge and Attitudes Among Transgender and Gender-Expansive Youth: A Replication and Extension.跨性别和性别多样化青年的生殖与生育知识及态度:一项重复与扩展研究
Transgend Health. 2023 Jul 28;8(4):328-336. doi: 10.1089/trgh.2021.0080. eCollection 2023 Aug.
7
"Lights and Shades" of Fertility Preservation in Transgender Men Patients: A Clinical and Pathological Review.变性男性患者生育力保存的“光影”:临床与病理综述
Life (Basel). 2023 Jun 1;13(6):1312. doi: 10.3390/life13061312.
8
Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.林奇综合征相关跨性别和性别多样化患者的癌症监测:遗传性胃肠道癌合作集团美洲分会的实践资源
Fam Cancer. 2023 Oct;22(4):437-448. doi: 10.1007/s10689-023-00341-4. Epub 2023 Jun 21.
9
Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen β receptor polymorphisms with clinical outcomes.出生时被指定为女性的跨性别者接受性别肯定治疗的安全性,以及雄激素和雌激素β受体多态性与临床结局的关系。
Endocrine. 2023 Sep;81(3):621-630. doi: 10.1007/s12020-023-03421-8. Epub 2023 Jun 16.
10
Presence of ovarian stromal aberrations after cessation of testosterone therapy in a transgender mouse model†.停服睾酮治疗后,转基因雄鼠模型卵巢间质出现异常†。
Biol Reprod. 2023 May 10;108(5):802-813. doi: 10.1093/biolre/ioad019.